Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients ...

A new study published in the Journal of American Medical Association found that in patients with myocardial infarction (MI) ...

Liberal blood transfusion after heart attack in patients with kidney disease (CKD) is not harmful, according to study results.

Patients with history of preeclampsia have increased risk for myocardial infarction and worse myocardial infarction outcomes.

Acute MI mortality has fallen, yet deaths from other diseases, including heart failure and hypertension, are on the rise.

Smartphone-based home screening significantly boosts chronic kidney disease (CKD) diagnosis and follow-up care, enhancing ...

U.S. heart disease mortality has dropped 66% since 1970, mainly due to fewer ischemic heart disease deaths. However, deaths ...

For patients with T2D, semaglutide seems to confer some advantage over empagliflozin in terms of mortality and CV event risks.

A new study highlights a sharp decline in deaths from heart attacks, while showing a significant rise in mortality from other heart conditions.

New data highlight a substantial decline in overall heart disease death rates during the past 50 years, along with a shift in ...

Forensics specialist Emmanuel Margueritte, MD, explains when physicians must flag a death for judicial review under France’s ...